COLOPLAST A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 836.4 DKK | -1.18% |
|
-8.75% | +8.34% |
| Feb. 27 | Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024. | CI |
| Feb. 14 | COLOPLAST : Q1 24: Many more positives beyond the margin beat |  |
| Sales 2024 * | 27.21B 3.89B | Sales 2025 * | 29.57B 4.22B | Capitalization | 190B 27.18B |
|---|---|---|---|---|---|
| Net income 2024 * | 5.33B 761M | Net income 2025 * | 6.2B 885M | EV / Sales 2024 * | 7.69 x |
| Net Debt 2024 * | 18.92B 2.7B | Net Debt 2025 * | 17.4B 2.49B | EV / Sales 2025 * | 7.02 x |
| P/E ratio 2024 * |
35.5
x | P/E ratio 2025 * |
30.5
x | Employees | 15,751 |
| Yield 2024 * |
2.42% | Yield 2025 * |
2.64% | Free-Float | 58.39% |
More Fundamentals
* Assessed data
More news
Latest transcript on Coloplast A/S
More recommendations
More press releases
More news
| 1 day | -1.79% | ||
| 1 week | -6.04% | ||
| Current month | -9.22% | ||
| 1 month | -9.22% | ||
| 3 months | +9.10% | ||
| 6 months | +17.69% | ||
| Current year | +9.64% |
1 week
836.40
929.20
1 month
836.40947.20
Current year
757.80977.60
1 year
689.20993.00
3 years
689.201 194.00
5 years
689.201 194.00
10 years
413.101 194.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 07-12-31 | |
| Director of Finance/CFO | 52 | 05-12-31 | |
| Chairman | 65 | 87-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 76 | 68-09-30 | |
Carsten Hellmann
BRD | Director/Board Member | 60 | 17-11-30 |
| Chairman | 65 | 87-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.81% | 192 M€ | +13.78% | ||
| 1.11% | 267 M€ | +6.08% | ||
| 0.96% | 49 M€ | +5.82% | ||
| 0.85% | 3 M€ | +9.95% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-01 | 836.4 | -1.18% | 83 878 |
| 24-04-30 | 846.4 | -1.79% | 274,442 |
| 24-04-29 | 861.8 | -0.19% | 237,270 |
| 24-04-26 | 863.4 | -0.09% | 422,774 |
| 24-04-25 | 864.2 | -6.27% | 380,397 |
Delayed Quote Nasdaq Copenhagen, April 30, 2024 at 10:59 am EDT
More quotes
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows:
- hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.;
- ostomy care products (36.8%): bags and equipment used following intestinal operations;
- wound care and skincare products (11.9%): wound dressings, bandages, creams and gels;
- voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc.
Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
2024-05-07
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
846.4
DKK
Average target price
917.1
DKK
Spread / Average Target
+8.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.64% | 27.27B | |
| -29.83% | 3.12B | |
| -15.97% | 2.53B | |
| +18.11% | 2.47B | |
| +3.70% | 2B | |
| -9.47% | 1.91B | |
| -2.22% | 1.48B | |
| +2.78% | 1.3B | |
| +18.92% | 1.18B | |
| +3.72% | 1.13B |
- Stock Market
- Equities
- COLO B Stock
